Researchers are exploring new ways to study skin diseases without needing invasive biopsies. In this work from the IMIBIC/University of Córdoba, scientists evaluated whether a simple tape-strip method could capture meaningful biological signals in alopecia areata, an autoimmune condition that targets hair follicles.

Alopecia areata occurs when the immune system mistakenly attacks hair follicles, leading to hair loss. Traditionally, understanding what is happening at the molecular level requires a biopsy, which involves removing a small piece of skin. This can be uncomfortable and not ideal for repeated monitoring over time. The tape-strip approach offers a much simpler alternative by collecting cells from the surface of the scalp.

Using RNA sequencing, the researchers analyzed gene activity from these tape-strip samples and compared them to traditional scalp biopsies. RNA sequencing allows scientists to see which genes are turned on or off, providing insight into immune activity and tissue health.

The results showed that tape-strip RNA sequencing successfully detected key immune signals known to drive alopecia areata. These included activation of immune pathways such as interferon signaling and cytotoxic immune cells, along with reduced activity in genes related to normal hair follicle function. Importantly, these patterns became stronger as disease severity increased.

The team also examined how patients responded to treatment with baricitinib, a drug that targets immune signaling pathways. Patients who responded to treatment showed a partial return toward normal gene activity patterns. In contrast, non-responders continued to show strong immune activation, indicating that the treatment was not effectively controlling the disease at a molecular level.

One of the most important findings was the strong agreement between tape-strip samples and traditional biopsies. This suggests that a non-invasive method can provide similar biological insights, making it possible to monitor disease progression and treatment response more easily and more frequently.

Overall, this work highlights the potential of RNA sequencing combined with tape-strip sampling as a practical tool for tracking immune activity in alopecia areata. It could help clinicians better understand how patients are responding to therapy and support more personalized treatment strategies in the future.